Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Optune Therapy of Recurrent Glioblastoma Multiforme Using Targeted Surgical Skull Remodeling

NCT02893137 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT02893137
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02893137 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Optune Therapy of Recurrent Glioblastoma Multiforme Using Targeted Surgical Skull Remodeling
Lead sponsor
Aarhus University Hospital
Phase
Phase 1
Overall status
Completed
Start date
October 1, 2016
Completion date
May 31, 2019
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma